Indian Test opener Prithvi Shaw has been suspended by the Board of Control for Cricket in India (BCCI) till November 15, 2019, for a doping violation. According to a BCCI release, Shaw had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups.
Mr Shaw had provided a urine sample as part of the BCCI’s anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore.
His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances.
On 16th July 2019, Mr Shaw was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) and provisionally suspended pending determination of the charge.
Mr Shaw responded to the charge but asserting that it was inadvertent, being caused by his ingestion of the over the counter cough syrup he had taken for his cough.
The BCCI was satisfied with Mr Shaw’s explanation. However, according to rules, he was suspended for an eight-month period of Ineligibility started to run from 16th March 2019, so that it will end at midnight on 15th November 2019.